Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma

Bronchodilator Properties and Safety in Asthma

Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma

Hide study title
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
65
Years old
Gender
All
Therapeutic area :
Respiratory
Disease :
Asthma
Study medication :
V0162
Phase : Phase II
Start Date :
26 September 2013
End date :
30 April 2014
Study ID : V00162 PI 202 4A
EudraCT/CTIS number : 2013-002517-35
CT.gov Number : NCT01951222
Send by email